Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jieting Liu

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Plos One|January 24, 2014
Exposure to perfluorooctane sulfonate in utero reduces testosterone production in rat fetal Leydig cellsBinghai Zhao, Li Li, Jieting Liu, et al.
Pharmacology|August 13, 2018
11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor Development by Lentiviral Screening Based on Computational ModelingHaifeng Liu, Lingyu Li, Chunlei Zhang, et al.
The Protein Journal|March 11, 2016
A Novel Strategy for the Preparation of Codon-Optimized Truncated Ulp1 and its Simplified Application to Cleavage the SUMO Fusion ProteinXiaohua Wang, Haifeng Liu, Yawei Liu, et al.
Biomaterials Research|May 18, 2023
Selenide-linked polydopamine-reinforced hybrid hydrogels with on-demand degradation and light-triggered nanozyme release for diabetic wound healingWenjing Li, Ying Bei, Xiangqiang Pan, et al.
International Journal of Biological Macromolecules|April 22, 2022
Heparan sulfate proteoglycans-mediated targeted delivery of TGF-β1-binding peptide to liver for improved anti-liver fibrotic activity in vitro and in vivoMinglu Ding, Zhen Huang, Xiaohua Wang, et al.
European Journal of Pharmacology|June 6, 2024
Targeting delivery of a novel TGF-β type I receptor-mimicking peptide to activated hepatic stellate cells for liver fibrosis therapy via inhibiting the TGF-β1/Smad and p38 MAPK signaling pathwaysXiaohui Liu, Xiaohua Wang, Liming Xu, et al.
Molecular Medicine (Cambridge, Mass.)|July 16, 2022
Recombinant truncated latency-associated peptide alleviates liver fibrosis in vitro and in vivo via inhibition of TGF-β/Smad pathwayXudong Song, Jiayi Shi, Jieting Liu, et al.
Acta Biochimica Et Biophysica Sinica|September 7, 2018
miR-23b promotes cutaneous wound healing through inhibition of the inflammatory responses by targeting ASK1Hongzhi Li, Xiao Han, Kuiyang Zuo, et al.
Journal of the American Society of Nephrology : JASN|February 4, 2016
MicroRNA-23b Targets Ras GTPase-Activating Protein SH3 Domain-Binding Protein 2 to Alleviate Fibrosis and Albuminuria in Diabetic NephropathyBinghai Zhao, Hongzhi Li, Jieting Liu, et al.
Journal of the American Society of Nephrology : JASN|September 20, 2017
Variations in MicroRNA-25 Expression Influence the Severity of Diabetic Kidney DiseaseYunshuang Liu, Hongzhi Li, Jieting Liu, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Plos One|January 24, 2014
Exposure to perfluorooctane sulfonate in utero reduces testosterone production in rat fetal Leydig cellsBinghai Zhao, Li Li, Jieting Liu, et al.
Pharmacology|August 13, 2018
11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor Development by Lentiviral Screening Based on Computational ModelingHaifeng Liu, Lingyu Li, Chunlei Zhang, et al.
The Protein Journal|March 11, 2016
A Novel Strategy for the Preparation of Codon-Optimized Truncated Ulp1 and its Simplified Application to Cleavage the SUMO Fusion ProteinXiaohua Wang, Haifeng Liu, Yawei Liu, et al.
Biomaterials Research|May 18, 2023
Selenide-linked polydopamine-reinforced hybrid hydrogels with on-demand degradation and light-triggered nanozyme release for diabetic wound healingWenjing Li, Ying Bei, Xiangqiang Pan, et al.
International Journal of Biological Macromolecules|April 22, 2022
Heparan sulfate proteoglycans-mediated targeted delivery of TGF-β1-binding peptide to liver for improved anti-liver fibrotic activity in vitro and in vivoMinglu Ding, Zhen Huang, Xiaohua Wang, et al.
European Journal of Pharmacology|June 6, 2024
Targeting delivery of a novel TGF-β type I receptor-mimicking peptide to activated hepatic stellate cells for liver fibrosis therapy via inhibiting the TGF-β1/Smad and p38 MAPK signaling pathwaysXiaohui Liu, Xiaohua Wang, Liming Xu, et al.
Molecular Medicine (Cambridge, Mass.)|July 16, 2022
Recombinant truncated latency-associated peptide alleviates liver fibrosis in vitro and in vivo via inhibition of TGF-β/Smad pathwayXudong Song, Jiayi Shi, Jieting Liu, et al.
Acta Biochimica Et Biophysica Sinica|September 7, 2018
miR-23b promotes cutaneous wound healing through inhibition of the inflammatory responses by targeting ASK1Hongzhi Li, Xiao Han, Kuiyang Zuo, et al.
Journal of the American Society of Nephrology : JASN|February 4, 2016
MicroRNA-23b Targets Ras GTPase-Activating Protein SH3 Domain-Binding Protein 2 to Alleviate Fibrosis and Albuminuria in Diabetic NephropathyBinghai Zhao, Hongzhi Li, Jieting Liu, et al.
Journal of the American Society of Nephrology : JASN|September 20, 2017
Variations in MicroRNA-25 Expression Influence the Severity of Diabetic Kidney DiseaseYunshuang Liu, Hongzhi Li, Jieting Liu, et al.
Pageof 5